3 ·Filed Jul 6, 2026

TAK

TAKEDA PHARMACEUTICAL CO LTD
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago SEC0001395064-26-000240
Form 3 — initial insider ownership statement
Actionable Insight • Neutral

This is a routine initial ownership filing by a new insider. No trading signal. Monitor for future Form 4 filings to track any subsequent open-market purchases or sales by this insider.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
TAK ▲ +9.59% at T+60d
NEUTRAL call ✓ call won +9.59% · α vs SPY +7.68% · entry $16.89 → $18.51
Entry anchored
Jul 6, 11:30 AM ET
via exchange tick
T+1d
+0.41%
call +0.41% · α +0.89%
$16.96
settled 3mo ago
T+5d
-1.95%
call -1.95% · α -2.44%
$16.56
settled 3mo ago
T+20d
+1.18%
call +1.18% · α +1.75%
$17.09
settled 2mo ago
T+60d
+9.59%
call +9.59% · α +7.68%
$18.51
settled 3d ago

Price Chart

Loading chart...

Executive Summary

Bruce Broussard filed a Form 3 initial statement of beneficial ownership with the SEC, reporting 795 American Depositary Shares in Takeda Pharmaceutical Co Ltd. The filing also includes a power of attorney authorizing legal counsel to execute future Section 16 filings. This is a routine administrative filing by a new insider and has no material impact on the company's operations or financials.

Key Facts

  • Bruce Broussard filed a Form 3 initial statement of beneficial ownership
  • Reports beneficial ownership of 795 American Depositary Shares in Takeda Pharmaceutical Co Ltd
  • Filing includes a power of attorney for Section 16 and Rule 144 filings
  • No material financial data, guidance, or operational changes disclosed

Financial Impact

No material financial impact; 795 ADS stake is negligible relative to Takeda's $2.4B market cap

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
68% bullish (19 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001395064-26-000240
Document: 0001395064-26-000240-index-headers.html0001395064-26-000240
Document: 0001395064-26-000240-index.html0001395064-26-000240
Document: 0001395064-26-000240.txt0001395064-26-000240
13 reports for TAK
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for TAK — sortable, filterable
TypeNow
Sep 14, 2026
18d ago
6-K
BULLISH ★ 7/10
$18.60 $18.89▲ +1.56%▲ +1.45%$17.86 (−3.98%)
Aug 21, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$18.18 $18.03▼ −0.83%▼ −1.30%$17.86 (−1.76%)
Aug 19, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$18.34 $18.23▼ −0.60%▼ −0.21%$17.86 (−2.62%)
Aug 14, 2026
7w ago
Court Ruling
NEUTRAL ★ 4/10
$17.63 $18.18▲ +3.12%▲ +4.49%$17.86 (+1.30%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$17.39 $18.13▲ +4.26%▲ +6.22%$17.86 (+2.70%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$17.39 $18.13▲ +4.26%▲ +6.22%$17.86 (+2.70%)
Jul 9, 2026
12w ago
6-K
NEUTRAL ★ 2/10
$16.61 $16.73▲ +0.72%▲ +0.85%$17.86 (+7.53%)
Jul 8, 2026
12w ago
6-K
NEUTRAL ★ 2/10
$16.75 $16.39▼ −2.15%▼ −3.01%$17.86 (+6.63%)
Jul 6, 2026
12w ago
3
NEUTRAL ★ 2/10
$16.89 $16.56▼ −1.95%▼ −2.44%$17.86 (+5.74%)
Jun 29, 2026
13w ago
6-K
NEUTRAL ★ 2/10
$15.98 $16.89▲ +5.69%▲ +4.31%$17.86 (+11.76%)
Showing 10 of 13

US Market Status

Market Closed — Opens Mon (65h)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access